This case study profiles how a federally qualified health center (FQHC) in New York provides integrated medical and behavioral health care services for individuals with opioid addiction.
This document provides a template for an EPIC electronic health record note for documenting that the service was provided via telemedicine due to the COVID-19 pandemic.
This 4-page guide from the Providers Clinical Support System is designed to provide information for clinicians on using telemedicine to treat opioid use disorder (OUD) during the COVID-19 pandemic. This guide includes frequently asked questions about prescribing medications for OUD during this time,
This 4 page guide from the New York State Office of Mental Health addesses approaches to reducing stress during the COVID-19 pandemic.
This 1-page guide from the Montifiore Health System provides information on managing stress and maintaining function during the COVID-19 pandemic. The information is based on acceptance and commitment therapy (ACT) treatment models.
This memo outlines policies adopted by Montifiore Health System to continue patient access to buprenorphine treatment during the COVID-19 pandemic.
This 1-page guide from Montifiore Health Systems guides providers in prescribing buprenorphine during the COVID-19 pandemic. This information sheet discusses telemedicine best practices and changes in regulatory guidance during the pandemic,
This document provides a template for an EPIC electronic health record note for a clinician providing a telemedicine visit for a continuing patient treated with buprenorphine for opioid use disorder during the COVID-19 pandemic.
This 1-page patient guide to buprenorphine treatment from Montifiore Health System, created specifically for care during the COVID-19 pandemic, discusses how clinicians will maintain treatment though telephonic visits, provides advice on stress reduction and avoiding relapse, and offers recommendations to ensure patient safety and health.
This document provides a template for an EPIC electronic health record note for a prescriber inducting a patient onto buprenorphine through telemedicine during the COVID-19 pandemic.